// App-Quantinova.ai

PB0196 : First-in-Human Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ONO-7684, an Oral Small Molecule Factor XIa Inhibitor in Healthy Subjects

Researchers

Presenter

  • D. Beale

Principal Investigators

  • J. Dennison

  • K.-M. Chavele

  • K. Yoneda

  • P. Smith

  • M. Bruce

Medical Centers

  • Chugai Pharma UK Ltd, London, United Kingdom

  • Hammersmith Medicines Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

  • Pharmacokinetics

  • Pharmacodynamics

  • Double Blind/Blinded

  • Single Ascending Dose

  • Multiple Ascending Dose

  • Controlled

  • First-In-Human

Phase

  • NA

Study Id's

  • NCT03919890

Sponsors

  • ONO PHARMACEUTICAL CO., LTD.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved